
Package | Dosage | Price | Price per Dose | |
---|---|---|---|---|
Dosage: 90/400mg | ||||
56 pill | 90/400mg | AUD5,170.83 | AUD92.34 | |
28 pill | 90/400mg | AUD3,102.80 | AUD110.82 |

Harvoni Description
Overview of Harvoni
Harvoni is a prescription medication used to treat chronic hepatitis C virus (HCV) infection. It combines two active ingredients, ledipasvir and sofosbuvir, which work together to inhibit the replication of the virus. This medication has revolutionized HCV treatment by offering a shorter, more effective therapy with fewer side effects compared to older treatments. In Australia, Harvoni is widely available through licensed pharmacies and is often prescribed by specialists or general practitioners experienced in managing hepatitis C.
Effectiveness and Benefits
Many patients in Australia have reported excellent outcomes after completing Harvoni therapy. Its high cure rate is one of the main reasons it is considered a first-line treatment. The medication is usually taken once daily for 8 to 12 weeks, depending on the patient's condition and previous treatment history. For most patients, Harvoni clears the virus completely, reducing the risk of liver disease progression and improving overall health.
Harvoni is generally well tolerated. Common side effects are mild and include fatigue, headache, and nausea. Because it does not require frequent injections or a lengthy treatment course, it is particularly appreciated by patients who prefer simpler, manageable treatment options. The convenience and high effectiveness of Harvoni make it a popular choice among Australian healthcare providers for treating hepatitis C.
Availability and Cost in Australia
As a therapy approved by the Therapeutic Goods Administration (TGA), Harvoni is available through authorized pharmacies across Australia. The medication is covered under the Pharmaceutical Benefits Scheme (PBS), making it more affordable for eligible patients. The subsidized cost significantly reduces financial barriers, allowing many Australians access to effective hepatitis C treatment.
Patients should consult with their healthcare provider to determine if they qualify for PBS coverage or if they need to explore private options. It’s important to obtain this medication through licensed pharmacies to ensure the medication's safety and authenticity, especially when ordering online.
Considerations and Precautions
Before starting Harvoni, patients should undergo a thorough medical evaluation, including blood tests to check liver function and viral load. It is essential to inform healthcare providers about any other medications being taken to avoid potential interactions. While Harvoni does not typically interfere with most common drugs, certain medications, especially those affecting the heart or other viral therapies, may require dose adjustments or monitoring.
Patients with underlying health conditions, such as liver cirrhosis, should discuss their condition with their doctor to tailor the treatment plan appropriately. As with all medications, pregnant or breastfeeding women should consult their healthcare provider before initiating therapy. Regular follow-up is recommended to monitor the treatment progress and ensure the virus has been eradicated.
Final Thoughts
Harvoni offers a highly effective and convenient treatment option for Australians living with hepatitis C. Its proven success in clearing the virus, combined with its manageable side effects profile, makes it a significant advancement in HCV care. When prescribed and taken under medical supervision, Harvoni can help patients regain their health and reduce the long-term complications associated with chronic hepatitis C infection.